Ilan Ganot - Jan 27, 2022 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
CEO & President, Director
Signature
/s/ Erin P. Brennan as attorney-in-fact for Ilan Ganot
Stock symbol
SLDB
Transactions as of
Jan 27, 2022
Transactions value $
$0
Form type
4
Date filed
1/31/2022, 04:32 PM
Next filing
Mar 8, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLDB Employee Stock Option (Right to Buy) Award $0 +466K $0.00 466K Jan 27, 2022 Common Stock 466K $1.13 Direct F1
transaction SLDB Restricted Stock Units Award $0 +233K $0.00 233K Jan 27, 2022 Common Stock 233K Direct F2, F3
transaction SLDB Employee Stock Option (Right to Buy) Award $0 +46.4K $0.00 46.4K Jan 27, 2022 Common Stock 46.4K $1.13 Wife F1
transaction SLDB Restricted Stock Units Award $0 +23.3K $0.00 23.3K Jan 27, 2022 Common Stock 23.3K Wife F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on January 27, 2022 and vests in four equal annual installments on the anniversary of the grant date.
F2 Each restricted stock unit represents a contingent right to receive one share of the Issuers common stock.
F3 The restricted stock units were granted on January 27, 2022 and vest on the same schedule as set forth in footnote (1) above.